Caribou Biosciences Inc
CRBU
Market Cap$168.98M
Close$
$-1.99
207.4% downside
Current Fair Value
207.4% downsideOvervalued by 207.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $168.98 Million |
|---|---|
| Enterprise Value | $196.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.38 |
| Beta | 2.27 |
| Outstanding Shares | 90,340,932 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.37 |
|---|---|
| PEG | -3.15 |
| Price to Sales | - |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 28.96 |
| Enterprise Value to EBIT | -1.26 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Caribou Biosciences Inc
2,021 employees